PyInvesting

Market research

CLPT Clearpoint Neuro Inc

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
469M
P/E ratio
Not available
Analyst target
25.6667
Dividend yield
Not available
Beta
1.27

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

ClearPoint Neuro, Inc is currently in a long term uptrend where the price is trading 8.1% above its 200 day moving average.

From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 27.8.

ClearPoint Neuro, Inc's total revenue rose by 15.8% to $4M since the same quarter in the previous year.

Its net income has increased by 3.9% to $-2M since the same quarter in the previous year.

Finally, its free cash flow fell by 290.2% to $-2M since the same quarter in the previous year.

Based on the above factors, ClearPoint Neuro, Inc gets an overall score of 4/5.